Pricing Log in Create free account

Sana Biotechnology, Inc. (SANA) vs Solid Biosciences Inc. (SLDB)

Sana Biotechnology, Inc. and Solid Biosciences Inc. are both Biotechnology companies. Sana Biotechnology, Inc. and Solid Biosciences Inc. are of similar size ($700.5M and $662.7M). Across the 8 metrics below, Solid Biosciences Inc. leads on 5 and Sana Biotechnology, Inc. on 3.

Valuation

Metric SANA SLDB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 88.22 9.40
P/B 4.53 2.90 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 57.17 9.02
Earnings yield (32.07%) (27.20%) (32.88%)
Free cash flow yield (19.12%) (20.18%) (23.13%)

Profitability

Metric SANA SLDB Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (152.87%) (76.87%) (51.96%)
Return on assets (53.41%) (64.86%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SANA SLDB Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 17.24% 34.97% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SANA SLDB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.38 11.99 4.97
Net debt to EBITDA 0.60 1.05 1.01

Dividend

Metric SANA SLDB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SANA SLDB Biotechnology median
Market cap 700.50m 662.65m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack